Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (6)
2022
-
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871
2017
-
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 25, pp. E4951-E4960
2013
-
An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility
PLoS ONE, Vol. 8, Núm. 9
-
Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
Cancer Discovery, Vol. 3, Núm. 5, pp. 520-533
2012
-
Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line
Nuclear Medicine and Biology, Vol. 39, Núm. 8, pp. 1275-1280
-
Genome-wide analysis of Pax8 binding provides new insights into thyroid functions
BMC Genomics, Vol. 13, Núm. 1